Computational Study and Modified Design of Selective Dopamine D3 Receptor Agonists

Area of Science:

• Medicinal Chemistry
• Neuropharmacology
• Computational Chemistry

Background:

• The dopamine D3 receptor (D3R) is a key therapeutic target for neurological conditions, including Parkinson's disease.
• Developing potent and selective D3R agonists is a significant area of research for treating these disorders.

Purpose of the Study:

• To design novel, potent, and selective dopamine D3 receptor agonists using computational methods.
• To elucidate the atomic-level interactions governing D3R agonist activity and selectivity.

Main Methods:

• Comparative molecular field analysis (CoMFA) for 3D-QSAR and 3D-QSSR on 40 known D3R agonists.
• Molecular docking studies to analyze binding modes with the D3 receptor.
• Design and in silico evaluation of novel agonist candidates based on QSAR/QSSR models.

Main Results:

• CoMFA models demonstrated strong predictive capabilities for both structure-activity (r(2)=0.982, q(2)=0.503) and structure-selectivity relationships (r(2)=0.876, q(2)=0.436).
• Docking studies revealed key hydrogen bond and hydrophobic interactions between agonists and D3 receptor residues.
• Six novel molecules were designed, exhibiting enhanced activity and selectivity, with predicted low hepatotoxicity (<0.5).

Conclusions:

• 3D-QSAR/QSSR and molecular docking are effective tools for understanding D3R agonist interactions.
• The study provides a strong foundation for the future design of novel, selective dopamine D3 agonists.
• Designed compounds show promise for therapeutic applications in nervous system disorders.